A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

For months, college student Breeze Hunter, 22, felt pressure and pain in her head. “I had a lot of fluid in my ears, which ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...

A novel drug combination targeting LSD1 and GSK3 shows promise in treating acute myeloid leukemia by promoting cell ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.